|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (1974.07) |
| C07D 405/12 | (1974.07) | ||
| A61K 31/519 | (2000.01) | ||
| A61P 35/00 | (2000.01) | ||
| A61P 29/00 | (2000.01) | ||
| A61P 31/12 | (2000.01) |
| (11) | Number of the document | 3882250 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21165852.1 |
| Date of filing the European patent application | 2015-12-23 | |
| (97) | Date of publication of the European application | 2021-09-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-02-15 |
| (46) | Date of publication of the claims translation | 2023-05-25 |
| (72) |
LAPIERRE, Jean-Marc , US
EATHIRAJ, Sudharshan , US
NAMDEV, Nivedita , US
SCHWARTZ, Brian , US
OTA, Yusuke , JP
MOMOSE, Takayuki , JP
TSUNEMI, Tomoyuki , JP
INAGAKI, Hiroaki , JP
NAKAYAMA, Kiyoshi , JP
|
| (73) |
ArQule, Inc. ,
One Wall Street, Burlington, MA 01803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Tetrahidropiranilamino-pirolopirimidinonas, skirtas panaudoti BTK nulemtų sutrikimų gydymui |
| TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE FOR USE IN TREATING BTK-MEDIATED DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2024-11-12 | 10 | 231.00 EUR |
| 2025-12-23 |